Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2463925rdf:typepubmed:Citationlld:pubmed
pubmed-article:2463925lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:2463925lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:2463925lifeskim:mentionsumls-concept:C0935597lld:lifeskim
pubmed-article:2463925lifeskim:mentionsumls-concept:C0030580lld:lifeskim
pubmed-article:2463925lifeskim:mentionsumls-concept:C0034826lld:lifeskim
pubmed-article:2463925lifeskim:mentionsumls-concept:C0205245lld:lifeskim
pubmed-article:2463925lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:2463925pubmed:issue3lld:pubmed
pubmed-article:2463925pubmed:dateCreated1989-3-9lld:pubmed
pubmed-article:2463925pubmed:abstractTextThe muscarinic agonist, carbamylcholine, stimulated amylase secretion in rat parotid acini 6-fold, the 86Rb efflux 5-fold, the 45Ca efflux 5-fold and the accumulation of inositol monophosphate, bisphosphate, trisphosphate and tetrakisphosphate 4-, 4-, 3- and 3-fold, respectively. The EC50 of carbamylcholine on these parameters were 0.4, 0.5, 1.3, 12, 12, 6 and 9 microM, suggesting spareness between phospholipase C activation and amylase secretion. These muscarinic responses were inhibited by four muscarinic antagonists with an order of potency on all parameters and on receptor occupancy (using N-[methyl-3H]scopolamine as a tracer): atropine greater than hexahydrosiladifenidol greater than pirenzepine greater than AF-DX 116. The pA2 of these antagonists on carbamylcholine-stimulated amylase secretion were 9.72 for atropine, 8.14 for hexahydrosiladifenidol, 7.16 for pirenzepine and 6.22 for AF-DX 116, indicating that the parotid muscarinic receptors were of an M2 subtype 83-fold more sensitive to hexahydrosiladifenidol than to AF-DX 116.lld:pubmed
pubmed-article:2463925pubmed:languageenglld:pubmed
pubmed-article:2463925pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2463925pubmed:citationSubsetIMlld:pubmed
pubmed-article:2463925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2463925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2463925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2463925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2463925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2463925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2463925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2463925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2463925pubmed:statusMEDLINElld:pubmed
pubmed-article:2463925pubmed:monthJullld:pubmed
pubmed-article:2463925pubmed:issn0014-2999lld:pubmed
pubmed-article:2463925pubmed:authorpubmed-author:ChristopheJJlld:pubmed
pubmed-article:2463925pubmed:authorpubmed-author:WinandJJlld:pubmed
pubmed-article:2463925pubmed:authorpubmed-author:DehayeJ PJPlld:pubmed
pubmed-article:2463925pubmed:authorpubmed-author:MarinoAAlld:pubmed
pubmed-article:2463925pubmed:authorpubmed-author:PoloczekPPlld:pubmed
pubmed-article:2463925pubmed:authorpubmed-author:SoukiasYYlld:pubmed
pubmed-article:2463925pubmed:issnTypePrintlld:pubmed
pubmed-article:2463925pubmed:day14lld:pubmed
pubmed-article:2463925pubmed:volume151lld:pubmed
pubmed-article:2463925pubmed:ownerNLMlld:pubmed
pubmed-article:2463925pubmed:authorsCompleteYlld:pubmed
pubmed-article:2463925pubmed:pagination427-34lld:pubmed
pubmed-article:2463925pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2463925pubmed:meshHeadingpubmed-meshheading:2463925-...lld:pubmed
pubmed-article:2463925pubmed:meshHeadingpubmed-meshheading:2463925-...lld:pubmed
pubmed-article:2463925pubmed:meshHeadingpubmed-meshheading:2463925-...lld:pubmed
pubmed-article:2463925pubmed:meshHeadingpubmed-meshheading:2463925-...lld:pubmed
pubmed-article:2463925pubmed:meshHeadingpubmed-meshheading:2463925-...lld:pubmed
pubmed-article:2463925pubmed:meshHeadingpubmed-meshheading:2463925-...lld:pubmed
pubmed-article:2463925pubmed:meshHeadingpubmed-meshheading:2463925-...lld:pubmed
pubmed-article:2463925pubmed:meshHeadingpubmed-meshheading:2463925-...lld:pubmed
pubmed-article:2463925pubmed:meshHeadingpubmed-meshheading:2463925-...lld:pubmed
pubmed-article:2463925pubmed:meshHeadingpubmed-meshheading:2463925-...lld:pubmed
pubmed-article:2463925pubmed:meshHeadingpubmed-meshheading:2463925-...lld:pubmed
pubmed-article:2463925pubmed:meshHeadingpubmed-meshheading:2463925-...lld:pubmed
pubmed-article:2463925pubmed:meshHeadingpubmed-meshheading:2463925-...lld:pubmed
pubmed-article:2463925pubmed:year1988lld:pubmed
pubmed-article:2463925pubmed:articleTitleFunctional characterization of muscarinic receptors in rat parotid acini.lld:pubmed
pubmed-article:2463925pubmed:affiliationDepartment of Biochemistry and Nutrition, Medical School, Université Libre de Bruxelles, Belgium.lld:pubmed
pubmed-article:2463925pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2463925pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:2463925pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2463925lld:pubmed